Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1549 to 1550 of 1550 entries
Sorted by: Best Match Show Resources per page
Hands that heal should not bleed.

Annals of medicine and surgery (2012)

Karn M, Phuyal A.
PMID: 34484729
Ann Med Surg (Lond). 2021 Aug 25;69:102759. doi: 10.1016/j.amsu.2021.102759. eCollection 2021 Sep.

No abstract available.

Cite
Karn M, Phuyal A. Hands that heal should not bleed. Ann Med Surg (Lond). 2021;69:102759doi: 10.1016/j.amsu.2021.102759.
Karn, M., & Phuyal, A. (2021). Hands that heal should not bleed. Annals of medicine and surgery (2012), 69102759. https://doi.org/10.1016/j.amsu.2021.102759
Karn, Mitesh, and Phuyal, Anusha. "Hands that heal should not bleed." Annals of medicine and surgery (2012) vol. 69 (2021): 102759. doi: https://doi.org/10.1016/j.amsu.2021.102759
Karn M, Phuyal A. Hands that heal should not bleed. Ann Med Surg (Lond). 2021 Aug 25;69:102759. doi: 10.1016/j.amsu.2021.102759. eCollection 2021 Sep. PMID: 34484729; PMCID: PMC8405974.
Copy Download .nbib Format: NLM
Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry.

Multiple sclerosis (Houndmills, Basingstoke, England)

Theodorsdottir A, Debrabant B, Magyari M, Kant M, Rasmussen PV, Malmberg CF, Norberg IA, Hansen V, Bech D, Schmidt MF, Schreiber K, Frederiksen JL, Sellebjerg F, Illes Z.
PMID: 33779361
Mult Scler. 2021 Dec;27(14):2254-2266. doi: 10.1177/13524585211003291. Epub 2021 Mar 29.

OBJECTIVE: To investigate clinical outcomes in a real-world setting in the complete population-based cohort of alemtuzumab-treated MS patients in Denmark.METHODS: Data were retrieved from The Danish Multiple Sclerosis Registry between 2009 and 2019. Demographic and disease-specific patient parameters related...

Cite
Theodorsdottir A, Debrabant B, Magyari M, et al. Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry. Mult Scler. 2021;27(14):2254-2266doi: 10.1177/13524585211003291.
Theodorsdottir, A., Debrabant, B., Magyari, M., Kant, M., Rasmussen, P. V., Malmberg, C. F., Norberg, I. A., Hansen, V., Bech, D., Schmidt, M. F., Schreiber, K., Frederiksen, J. L., Sellebjerg, F., & Illes, Z. (2021). Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry. Multiple sclerosis (Houndmills, Basingstoke, England), 27(14), 2254-2266. https://doi.org/10.1177/13524585211003291
Theodorsdottir, Asta, et al. "Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry." Multiple sclerosis (Houndmills, Basingstoke, England) vol. 27,14 (2021): 2254-2266. doi: https://doi.org/10.1177/13524585211003291
Theodorsdottir A, Debrabant B, Magyari M, Kant M, Rasmussen PV, Malmberg CF, Norberg IA, Hansen V, Bech D, Schmidt MF, Schreiber K, Frederiksen JL, Sellebjerg F, Illes Z. Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry. Mult Scler. 2021 Dec;27(14):2254-2266. doi: 10.1177/13524585211003291. Epub 2021 Mar 29. PMID: 33779361.
Copy Download .nbib Format: NLM
Showing 1549 to 1550 of 1550 entries